×
Entrez Id:
3417
Gene Symbol:
IDH1
IDH1
0.400
GeneticVariation
disease
BEFREE
36 (57%) had oligodendroglioma and 27 astrocytoma.IDH-1 mutation was present in 53 (84%).
30292978
2018
×
Entrez Id:
1326
Gene Symbol:
MAP3K8
MAP3K8
0.010
AlteredExpression
disease
BEFREE
5 (an EST ) was more expressed by GDA analysis in histologically normal adjacent brain tissue than in the corresponding oligodendroglioma .
11172594
2001
×
Entrez Id:
6783
Gene Symbol:
SULT1E1
SULT1E1
0.010
AlteredExpression
disease
BEFREE
5 (an EST ) was more expressed by GDA analysis in histologically normal adjacent brain tissue than in the corresponding oligodendroglioma .
11172594
2001
×
Entrez Id:
7124
Gene Symbol:
TNF
TNF
0.010
AlteredExpression
disease
BEFREE
Tumor necrosis factor modulates transcription of myelin basic protein gene through nuclear factor kappa B in a human oligodendroglioma cell line.
12175864
2002
×
Entrez Id:
1641
Gene Symbol:
DCX
DCX
0.010
AlteredExpression
disease
BEFREE
DCX was highly expressed in both high-grade invasive tumors (glioblastoma, n=11; anaplastic astrocytoma/oligoastrocytoma, n=7; and medulloblastoma/PNET, n=6) and low-grade invasive tumors (oligodendroglioma , n=3; and astrocytoma/oligoastrocytoma, n=5).
16195916
2005
×
Entrez Id:
27165
Gene Symbol:
GLS2
GLS2
0.010
AlteredExpression
disease
BEFREE
LGA mRNA was also relatively high in ganglioglioma which contains a discernable proportion of neuronal cells, and in oligodendroglioma .
17940881
2008
×
Entrez Id:
3956
Gene Symbol:
LGALS1
LGALS1
0.010
Biomarker
disease
BEFREE
Galectin 1 has been shown to be involved in Hs683 oligodendroglioma chemoresistance, neoangiogenesis, and migration.
19412433
2009
×
Entrez Id:
92140
Gene Symbol:
MTDH
MTDH
0.010
Biomarker
disease
BEFREE
AEG-1 might represent a novel, useful diagnostic and prognostic marker for oligodendroglioma and play a role during the development and progression of the disease.
20236756
2010
×
Entrez Id:
596
Gene Symbol:
BCL2
BCL2
0.030
Biomarker
disease
BEFREE
Bcl-2 promotes malignant progression in a PDGF-B-dependent murine model of oligodendroglioma .
21171016
2011
×
Entrez Id:
1956
Gene Symbol:
EGFR
EGFR
0.050
AlteredExpression
disease
BEFREE
EGFR expression stratifies oligodendroglioma behavior.
21839716
2011
×
Entrez Id:
9118
Gene Symbol:
INA
INA
0.020
AlteredExpression
disease
BEFREE
Alpha internexin expression related with molecular characteristics in adult glioblastoma and oligodendroglioma .
23579442
2013
×
Entrez Id:
3560
Gene Symbol:
IL2RB
IL2RB
0.010
AlteredExpression
disease
BEFREE
Interleukin 2 receptor beta chain expressed in an oligodendroglioma line binds interleukin 2 and delivers growth signal.
2395860
1990
×
Entrez Id:
47
Gene Symbol:
ACLY
ACLY
0.010
GeneticVariation
disease
BEFREE
ACLY or phospho-ACLY were similarly reduced in CIC-mutant 1p19q co-deleted oligodendroglioma patient samples.
25277207
2014
LOC110806263
0.020
GeneticVariation
disease
BEFREE
TERT promoter mutations were highly frequent in glioblastoma (83.9%), urothelial carcinoma (64.5%), oligodendroglioma (70.0%), medulloblastoma (33.3%) and hepatocellular carcinoma (31.4%).
25843513
2015
×
Entrez Id:
5777
Gene Symbol:
PTPN6
PTPN6
0.010
Biomarker
disease
BEFREE
PTPN6 and CUL3 were the key hub genes identified in the astrocytoma relative to the oligodendroglioma .
28924174
2017
×
Entrez Id:
23152
Gene Symbol:
CIC
CIC
0.070
GeneticVariation
disease
BEFREE
CIC loss-of-function mutations are frequently observed in several human neoplasms such as oligodendroglioma , and lung and gastric carcinoma.
28985030
2017
×
Entrez Id:
29998
Gene Symbol:
BICRA
BICRA
0.020
Biomarker
disease
BEFREE
Glioma tumor suppressor candidate region gene 1 (GLTSCR1 ) is associated with the progression of oligodendroglioma .
30405818
2018
×
Entrez Id:
673
Gene Symbol:
BRAF
BRAF
0.050
GeneticVariation
disease
BEFREE
BRAF V600E mutant oligodendroglioma -like tumors with chromosomal instability in adolescents and young adults.
31630459
2019
×
Entrez Id:
673
Gene Symbol:
BRAF
BRAF
0.050
GeneticVariation
disease
BEFREE
A BRAF (V600E ) mutation was also detected in one oligodendroglioma , and a BRAF(A598V ) in one diffuse astrocytoma.
22568401
2012
×
Entrez Id:
3417
Gene Symbol:
IDH1
IDH1
0.400
GeneticVariation
disease
BEFREE
A better prognosis was significantly associated with combined IDH1 mutation and MGMT methylation status (both positive vs both negative, HR 0.079 [95% CI 0.008-0.579], p=0.012), as well as histology (OG vs DA and OA, HR 0.158 [95% CI 0.022-0.674], p=0.011) and tumor size (<6 cm vs ≥6 cm, HR 0.120 [95% CI 0.017-0.595], p=0.008).
26276726
2015
×
Entrez Id:
4255
Gene Symbol:
MGMT
MGMT
0.060
GeneticVariation
disease
BEFREE
A better prognosis was significantly associated with combined IDH1 mutation and MGMT methylation status (both positive vs both negative, HR 0.079 [95% CI 0.008-0.579], p=0.012), as well as histology (OG vs DA and OA, HR 0.158 [95% CI 0.022-0.674], p=0.011) and tumor size (<6 cm vs ≥6 cm, HR 0.120 [95% CI 0.017-0.595], p=0.008).
26276726
2015
×
Entrez Id:
3418
Gene Symbol:
IDH2
IDH2
0.400
GeneticVariation
disease
BEFREE
A c.515G>T (p.R172M ) mutation of the IDH2 gene was only identified in a grade II oligodendroglioma patient which was wild-type for IDH1.
21643842
2011
×
Entrez Id:
3417
Gene Symbol:
IDH1
IDH1
0.400
GeneticVariation
disease
BEFREE
A c.515G>T (p.R172M ) mutation of the IDH2 gene was only identified in a grade II oligodendroglioma patient which was wild-type for IDH1 .
21643842
2011
×
Entrez Id:
3417
Gene Symbol:
IDH1
IDH1
0.400
GeneticVariation
disease
BEFREE
A total of 135 cases consisted of 38 IDH -mutant [17 astrocytoma (AC), 13 oligodendroglioma (OD) and eight glioblastoma (GBM)], 87 IDH -wildtype (six AC, three OD and 78 GBM), and 10 diffuse midline glioma, H3K27M-mutant.
30710203
2019
×
Entrez Id:
3418
Gene Symbol:
IDH2
IDH2
0.400
GeneticVariation
disease
BEFREE
A total of 135 cases consisted of 38 IDH -mutant [17 astrocytoma (AC), 13 oligodendroglioma (OD) and eight glioblastoma (GBM)], 87 IDH -wildtype (six AC, three OD and 78 GBM), and 10 diffuse midline glioma, H3K27M-mutant.
30710203
2019